EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, TTK Healthcare's enterprise value is ₹12,116 Mil.
TTK Healthcare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1,022 Mil. Therefore, TTK Healthcare's EV-to-EBITDA for today is 11.85.
The historical rank and industry rank for TTK Healthcare's EV-to-EBITDA or its related term are showing as below:
BOM:507747'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6 Med: 17.23 Max: 34.36
Current: 11.85
During the past 13 years, the highest EV-to-EBITDA of TTK Healthcare was 34.36. The lowest was 6.00. And the median was 17.23.
BOM:507747's EV-to-EBITDA is ranked better than 60.31% of 708
companies
in the Drug Manufacturers industry
Industry Median: 14.76
vs BOM:507747: 11.85
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
TTK Healthcare EV-to-EBITDA Historical Data
The historical data trend for TTK Healthcare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of TTK Healthcare's EV-to-EBITDA
For the Drug Manufacturers - General subindustry, TTK Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TTK Healthcare's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TTK Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where TTK Healthcare's EV-to-EBITDA falls into.
TTK Healthcare EV-to-EBITDA Calculation
TTK Healthcare's EV-to-EBITDA for today is calculated as:
TTK Healthcare's current Enterprise Value is ₹12,116 Mil.
TTK Healthcare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,022 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
TTK Healthcare's PE Ratio for today is calculated as:
TTK Healthcare's share price for today is ₹1460.70.
TTK Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹43.540.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of TTK Healthcare's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
TTK Healthcare Ltd is an Indian pharmaceutical company. The company's operating segment includes Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods Division, and Others. Its Animal Welfare segment includes products for both Human and Veterinary use. The Consumer Products comprises of marketing and distribution of Woodwards's Gripe Water, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners and others. Protective Devices comprises of manufacturing and marketing of Male Contraceptives and other allied products. It generates maximum revenue from the Pharmaceuticals segment. Geographically, it derives a majority of revenue from India.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:507747 has been successfully added to your 